2023-2029 Global Exosome Therapeutics Industry Research & Trends Analysis Report
2023-2029 Global Exosome Therapeutics Industry Research & Trends Analysis Report
Insights into the Exosome Therapeutics Market include supply chain optimization, Exosome Therapeutics challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Research, the global market for Exosome Therapeutics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Exosome Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Exosome Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Monotherapy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Exosome Therapeutics include Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, EV Therapeutics, Evox Therapeutics, ExoCoBio, ILIAS Biologics and Rion, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Exosome Therapeutics. Report Highlights:
(1) Global Exosome Therapeutics market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Exosome Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Exosome Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Exosome Therapeutics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Exosome Therapeutics segment by type and by application and regional segment by type and by application.
(6) Exosome Therapeutics industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Monotherapy
Combination Therapy
Market segment by application, can be divided into
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Market segment by players, this report covers
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
1 Market Overview
1.1 Product Overview and Scope of Exosome Therapeutics
1.2 Global Exosome Therapeutics Market Size and Forecast
1.3 China Exosome Therapeutics Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Exosome Therapeutics Share in Global Market, 2018-2029
1.4.2 Exosome Therapeutics Market Size: China VS Global, 2018-2029
1.5 Exosome Therapeutics Market Dynamics
1.5.1 Exosome Therapeutics Market Drivers
1.5.2 Exosome Therapeutics Market Restraints
1.5.3 Exosome Therapeutics Industry Trends
1.5.4 Exosome Therapeutics Industry Policy
2 Global Competitive Situation by Company
2.1 Global Exosome Therapeutics Revenue by Company (2018-2023)
2.2 Global Exosome Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Exosome Therapeutics Concentration Ratio
2.4 Global Exosome Therapeutics Mergers & Acquisitions, Expansion Plans
2.5 Global Exosome Therapeutics Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Exosome Therapeutics Revenue by Company (2018-2023)
3.2 China Exosome Therapeutics Exosome Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Exosome Therapeutics, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Exosome Therapeutics Industry Chain
4.2 Exosome Therapeutics Upstream Analysis
4.3 Exosome Therapeutics Midstream Analysis
4.4 Exosome Therapeutics Downstream Analysis
5 Sights by Type
5.1 Exosome Therapeutics Classification
5.1.1 Monotherapy
5.1.2 Combination Therapy
5.2 By Type, Global Exosome Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Exosome Therapeutics Revenue, 2018-2029
6 Sights by Application
6.1 Exosome Therapeutics Segment by Application
6.1.1 Hospitals
6.1.2 Clinics & Ambulatory Centers
6.1.3 Cancer Research Institutes
6.1.4 Others
6.2 By Application, Global Exosome Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Exosome Therapeutics Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Exosome Therapeutics Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Exosome Therapeutics Market Size, 2018-2029
7.3 North America
7.3.1 North America Exosome Therapeutics Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Exosome Therapeutics Market Size Market Share
7.4 Europe
7.4.1 Europe Exosome Therapeutics Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Exosome Therapeutics Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Exosome Therapeutics Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Exosome Therapeutics Market Size Market Share
7.6 South America
7.6.1 South America Exosome Therapeutics Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Exosome Therapeutics Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Exosome Therapeutics Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Exosome Therapeutics Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Exosome Therapeutics Market Size, 2018-2029
8.3.2 By Company, U.S. Exosome Therapeutics Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Exosome Therapeutics Market Size, 2018-2029
8.4.2 By Company, Europe Exosome Therapeutics Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Exosome Therapeutics Market Size, 2018-2029
8.5.2 By Company, China Exosome Therapeutics Revenue Market Share, 2018-2023
8.5.3 By Type, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Exosome Therapeutics Market Size, 2018-2029
8.6.2 By Company, Japan Exosome Therapeutics Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Exosome Therapeutics Market Size, 2018-2029
8.7.2 By Company, South Korea Exosome Therapeutics Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Exosome Therapeutics Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Exosome Therapeutics Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Exosome Therapeutics Market Size, 2018-2029
8.9.2 By Company, India Exosome Therapeutics Revenue Market Share, 2018-2023
8.9.3 By Type, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Exosome Therapeutics Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Cellular Biomedicine Group
9.1.1 Cellular Biomedicine Group Company Information, Head Office, Market Area and Industry Position
9.1.2 Cellular Biomedicine Group Company Profile and Main Business
9.1.3 Cellular Biomedicine Group Exosome Therapeutics Models, Specifications and Application
9.1.4 Cellular Biomedicine Group Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.1.5 Cellular Biomedicine Group Recent Developments
9.2 Codiak BioSciences
9.2.1 Codiak BioSciences Company Information, Head Office, Market Area and Industry Position
9.2.2 Codiak BioSciences Company Profile and Main Business
9.2.3 Codiak BioSciences Exosome Therapeutics Models, Specifications and Application
9.2.4 Codiak BioSciences Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.2.5 Codiak BioSciences Recent Developments
9.3 Coya Therapeutics
9.3.1 Coya Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Coya Therapeutics Company Profile and Main Business
9.3.3 Coya Therapeutics Exosome Therapeutics Models, Specifications and Application
9.3.4 Coya Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.3.5 Coya Therapeutics Recent Developments
9.4 Curexsys
9.4.1 Curexsys Company Information, Head Office, Market Area and Industry Position
9.4.2 Curexsys Company Profile and Main Business
9.4.3 Curexsys Exosome Therapeutics Models, Specifications and Application
9.4.4 Curexsys Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.4.5 Curexsys Recent Developments
9.5 EV Therapeutics
9.5.1 EV Therapeutics Company Information, Head Office, Market Area and Industry Position
9.5.2 EV Therapeutics Company Profile and Main Business
9.5.3 EV Therapeutics Exosome Therapeutics Models, Specifications and Application
9.5.4 EV Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.5.5 EV Therapeutics Recent Developments
9.6 Evox Therapeutics
9.6.1 Evox Therapeutics Company Information, Head Office, Market Area and Industry Position
9.6.2 Evox Therapeutics Company Profile and Main Business
9.6.3 Evox Therapeutics Exosome Therapeutics Models, Specifications and Application
9.6.4 Evox Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.6.5 Evox Therapeutics Recent Developments
9.7 ExoCoBio
9.7.1 ExoCoBio Company Information, Head Office, Market Area and Industry Position
9.7.2 ExoCoBio Company Profile and Main Business
9.7.3 ExoCoBio Exosome Therapeutics Models, Specifications and Application
9.7.4 ExoCoBio Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.7.5 ExoCoBio Recent Developments
9.8 ILIAS Biologics
9.8.1 ILIAS Biologics Company Information, Head Office, Market Area and Industry Position
9.8.2 ILIAS Biologics Company Profile and Main Business
9.8.3 ILIAS Biologics Exosome Therapeutics Models, Specifications and Application
9.8.4 ILIAS Biologics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.8.5 ILIAS Biologics Recent Developments
9.9 Rion
9.9.1 Rion Company Information, Head Office, Market Area and Industry Position
9.9.2 Rion Company Profile and Main Business
9.9.3 Rion Exosome Therapeutics Models, Specifications and Application
9.9.4 Rion Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.9.5 Rion Recent Developments
9.10 SHIFTBIO
9.10.1 SHIFTBIO Company Information, Head Office, Market Area and Industry Position
9.10.2 SHIFTBIO Company Profile and Main Business
9.10.3 SHIFTBIO Exosome Therapeutics Models, Specifications and Application
9.10.4 SHIFTBIO Exosome Therapeutics Revenue and Gross Margin, 2018-2023
9.10.5 SHIFTBIO Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Exosome Therapeutics Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Exosome Therapeutics Market Restraints
Table 3. Exosome Therapeutics Market Trends
Table 4. Exosome Therapeutics Industry Policy
Table 5. Global Exosome Therapeutics Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Exosome Therapeutics Revenue Market Share by Company (2018-2023)
Table 7. Global Exosome Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Exosome Therapeutics Mergers & Acquisitions, Expansion Plans
Table 9. Global Exosome Therapeutics Manufacturers Product Type
Table 10. China Exosome Therapeutics Revenue by Company (2018-2023) & (US$ million)
Table 11. China Exosome Therapeutics Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Exosome Therapeutics Upstream (Raw Materials)
Table 13. Global Exosome Therapeutics Typical Customers
Table 14. Exosome Therapeutics Typical Distributors
Table 15. By Type, Global Exosome Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Exosome Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Exosome Therapeutics Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Exosome Therapeutics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Table 22. Cellular Biomedicine Group Company Information, Head Office, Market Area and Industry Position
Table 23. Cellular Biomedicine Group Company Profile and Main Business
Table 24. Cellular Biomedicine Group Exosome Therapeutics Models, Specifications and Application
Table 25. Cellular Biomedicine Group Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 26. Cellular Biomedicine Group Recent Developments
Table 27. Codiak BioSciences Company Information, Head Office, Market Area and Industry Position
Table 28. Codiak BioSciences Company Profile and Main Business
Table 29. Codiak BioSciences Exosome Therapeutics Models, Specifications and Application
Table 30. Codiak BioSciences Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 31. Codiak BioSciences Recent Developments
Table 32. Coya Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 33. Coya Therapeutics Company Profile and Main Business
Table 34. Coya Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 35. Coya Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 36. Coya Therapeutics Recent Developments
Table 37. Curexsys Company Information, Head Office, Market Area and Industry Position
Table 38. Curexsys Company Profile and Main Business
Table 39. Curexsys Exosome Therapeutics Models, Specifications and Application
Table 40. Curexsys Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 41. Curexsys Recent Developments
Table 42. EV Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 43. EV Therapeutics Company Profile and Main Business
Table 44. EV Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 45. EV Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 46. EV Therapeutics Recent Developments
Table 47. Evox Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 48. Evox Therapeutics Company Profile and Main Business
Table 49. Evox Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 50. Evox Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 51. Evox Therapeutics Recent Developments
Table 52. ExoCoBio Company Information, Head Office, Market Area and Industry Position
Table 53. ExoCoBio Company Profile and Main Business
Table 54. ExoCoBio Exosome Therapeutics Models, Specifications and Application
Table 55. ExoCoBio Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 56. ExoCoBio Recent Developments
Table 57. ILIAS Biologics Company Information, Head Office, Market Area and Industry Position
Table 58. ILIAS Biologics Company Profile and Main Business
Table 59. ILIAS Biologics Exosome Therapeutics Models, Specifications and Application
Table 60. ILIAS Biologics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 61. ILIAS Biologics Recent Developments
Table 62. Rion Company Information, Head Office, Market Area and Industry Position
Table 63. Rion Company Profile and Main Business
Table 64. Rion Exosome Therapeutics Models, Specifications and Application
Table 65. Rion Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 66. Rion Recent Developments
Table 67. SHIFTBIO Company Information, Head Office, Market Area and Industry Position
Table 68. SHIFTBIO Company Profile and Main Business
Table 69. SHIFTBIO Exosome Therapeutics Models, Specifications and Application
Table 70. SHIFTBIO Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 71. SHIFTBIO Recent Developments
List of Figure
Figure 1. Exosome Therapeutics Picture
Figure 2. Global Exosome Therapeutics Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Exosome Therapeutics Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Exosome Therapeutics Market Share of Global
Figure 5. Global Exosome Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Exosome Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Exosome Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Exosome Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Exosome Therapeutics Industry Chain
Figure 10. Monotherapy
Figure 11. Combination Therapy
Figure 12. By Type, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 14. Hospitals
Figure 15. Clinics & Ambulatory Centers
Figure 16. Cancer Research Institutes
Figure 17. Others
Figure 18. By Application, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 21. North America Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 23. Europe Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 27. South America Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Exosome Therapeutics Market Share, 2018-2023
Figure 32. By Type, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 34. Europe Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Exosome Therapeutics Market Share, 2018-2023
Figure 36. By Type, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 38. China Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Exosome Therapeutics Market Share, 2018-2023
Figure 40. By Type, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 42. Japan Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Exosome Therapeutics Market Share, 2018-2023
Figure 44. By Type, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Exosome Therapeutics Market Share, 2018-2023
Figure 48. By Type, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Exosome Therapeutics Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 54. India Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Exosome Therapeutics Market Share, 2018-2023
Figure 56. By Type, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Exosome Therapeutics Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Table 1. Exosome Therapeutics Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Exosome Therapeutics Market Restraints
Table 3. Exosome Therapeutics Market Trends
Table 4. Exosome Therapeutics Industry Policy
Table 5. Global Exosome Therapeutics Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Exosome Therapeutics Revenue Market Share by Company (2018-2023)
Table 7. Global Exosome Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Exosome Therapeutics Mergers & Acquisitions, Expansion Plans
Table 9. Global Exosome Therapeutics Manufacturers Product Type
Table 10. China Exosome Therapeutics Revenue by Company (2018-2023) & (US$ million)
Table 11. China Exosome Therapeutics Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Exosome Therapeutics Upstream (Raw Materials)
Table 13. Global Exosome Therapeutics Typical Customers
Table 14. Exosome Therapeutics Typical Distributors
Table 15. By Type, Global Exosome Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Exosome Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Exosome Therapeutics Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Exosome Therapeutics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Table 22. Cellular Biomedicine Group Company Information, Head Office, Market Area and Industry Position
Table 23. Cellular Biomedicine Group Company Profile and Main Business
Table 24. Cellular Biomedicine Group Exosome Therapeutics Models, Specifications and Application
Table 25. Cellular Biomedicine Group Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 26. Cellular Biomedicine Group Recent Developments
Table 27. Codiak BioSciences Company Information, Head Office, Market Area and Industry Position
Table 28. Codiak BioSciences Company Profile and Main Business
Table 29. Codiak BioSciences Exosome Therapeutics Models, Specifications and Application
Table 30. Codiak BioSciences Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 31. Codiak BioSciences Recent Developments
Table 32. Coya Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 33. Coya Therapeutics Company Profile and Main Business
Table 34. Coya Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 35. Coya Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 36. Coya Therapeutics Recent Developments
Table 37. Curexsys Company Information, Head Office, Market Area and Industry Position
Table 38. Curexsys Company Profile and Main Business
Table 39. Curexsys Exosome Therapeutics Models, Specifications and Application
Table 40. Curexsys Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 41. Curexsys Recent Developments
Table 42. EV Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 43. EV Therapeutics Company Profile and Main Business
Table 44. EV Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 45. EV Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 46. EV Therapeutics Recent Developments
Table 47. Evox Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 48. Evox Therapeutics Company Profile and Main Business
Table 49. Evox Therapeutics Exosome Therapeutics Models, Specifications and Application
Table 50. Evox Therapeutics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 51. Evox Therapeutics Recent Developments
Table 52. ExoCoBio Company Information, Head Office, Market Area and Industry Position
Table 53. ExoCoBio Company Profile and Main Business
Table 54. ExoCoBio Exosome Therapeutics Models, Specifications and Application
Table 55. ExoCoBio Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 56. ExoCoBio Recent Developments
Table 57. ILIAS Biologics Company Information, Head Office, Market Area and Industry Position
Table 58. ILIAS Biologics Company Profile and Main Business
Table 59. ILIAS Biologics Exosome Therapeutics Models, Specifications and Application
Table 60. ILIAS Biologics Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 61. ILIAS Biologics Recent Developments
Table 62. Rion Company Information, Head Office, Market Area and Industry Position
Table 63. Rion Company Profile and Main Business
Table 64. Rion Exosome Therapeutics Models, Specifications and Application
Table 65. Rion Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 66. Rion Recent Developments
Table 67. SHIFTBIO Company Information, Head Office, Market Area and Industry Position
Table 68. SHIFTBIO Company Profile and Main Business
Table 69. SHIFTBIO Exosome Therapeutics Models, Specifications and Application
Table 70. SHIFTBIO Exosome Therapeutics Revenue and Gross Margin, 2018-2023
Table 71. SHIFTBIO Recent Developments
List of Figure
Figure 1. Exosome Therapeutics Picture
Figure 2. Global Exosome Therapeutics Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Exosome Therapeutics Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Exosome Therapeutics Market Share of Global
Figure 5. Global Exosome Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Exosome Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Exosome Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Exosome Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Exosome Therapeutics Industry Chain
Figure 10. Monotherapy
Figure 11. Combination Therapy
Figure 12. By Type, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 14. Hospitals
Figure 15. Clinics & Ambulatory Centers
Figure 16. Cancer Research Institutes
Figure 17. Others
Figure 18. By Application, Global Exosome Therapeutics Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region, Global Exosome Therapeutics Revenue Market Share, 2018-2029
Figure 21. North America Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 23. Europe Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 27. South America Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Exosome Therapeutics Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Exosome Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Exosome Therapeutics Market Share, 2018-2023
Figure 32. By Type, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 34. Europe Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Exosome Therapeutics Market Share, 2018-2023
Figure 36. By Type, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 38. China Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Exosome Therapeutics Market Share, 2018-2023
Figure 40. By Type, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 42. Japan Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Exosome Therapeutics Market Share, 2018-2023
Figure 44. By Type, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Exosome Therapeutics Market Share, 2018-2023
Figure 48. By Type, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Exosome Therapeutics Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 54. India Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Exosome Therapeutics Market Share, 2018-2023
Figure 56. By Type, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Exosome Therapeutics Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Exosome Therapeutics Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Exosome Therapeutics Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Research Methodology:
Exosome Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|